Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Hepatitis

  Free Subscription


19.04.2021

1 AIDS
3 Am J Gastroenterol
2 Clin Infect Dis
1 Eur J Gastroenterol Hepatol
1 Gastroenterol Hepatol
1 Gastroenterology
1 Gut
4 Hepatology
3 J Hepatol
1 J Infect Dis
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AIDS

  1. SHITOLE SG, Lazar JM, Hanna DB, Kim RS, et al
    HIV, HCV and risk of new-onset left ventricular dysfunction: the women's interagency HIV study.
    AIDS. 2021 Apr 15. pii: 00002030-900000000-96421.
    PubMed         Abstract available


    Am J Gastroenterol

  2. SHARMA S, Saraya A
    Avoiding Beta Blockers in Patients of Hepatitis C Virus-Related Compensated Cirrhosis With Clinically Significant Portal Hypertension After Cure With Antivirals: Are We There Yet?
    Am J Gastroenterol. 2021 Apr 9. pii: 00000434-900000000-98829.
    PubMed        

  3. JI D, Chen Y, Shang Q, Liu H, et al
    Unreliable Estimation of Fibrosis Regression During Treatment by Liver Stiffness Measurement in Patients With Chronic Hepatitis B.
    Am J Gastroenterol. 2021 Apr 8. pii: 00000434-900000000-98824.
    PubMed         Abstract available

  4. KHALILI M, Kleiner DE, King WC, Sterling RK, et al
    Hepatic Steatosis and Steatohepatitis in a Large North American Cohort of Adults With Chronic Hepatitis B.
    Am J Gastroenterol. 2021 Apr 8. pii: 00000434-900000000-98823.
    PubMed         Abstract available


    Clin Infect Dis

  5. MERAT S, Sharifi AH, Poustchi H, Hajiani E, et al
    Erratum to: SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter Phase III Clinical Trial.
    Clin Infect Dis. 2021 Apr 15. pii: 6226813. doi: 10.1093/cid/ciaa1768.
    PubMed        

  6. LEE SK, Sung PS, Park SS, Min CK, et al
    Reactivation of resolved hepatitis B after daratumumab for multiple myeloma.
    Clin Infect Dis. 2021 Apr 13. pii: 6224403. doi: 10.1093.
    PubMed         Abstract available


    Eur J Gastroenterol Hepatol

  7. KUMADA T, Toyoda H, Yasuda S, Tada T, et al
    Usefulness of serial FIB-4 score measurement for predicting the risk of hepatocarcinogenesis after hepatitis C virus eradication.
    Eur J Gastroenterol Hepatol. 2021 Apr 9. pii: 00042737-900000000-97256.
    PubMed         Abstract available


    Gastroenterol Hepatol

  8. COSTA CA, Garcia JLR, Gandia MAR, Martos RF, et al
    FULMINANT LIVER FAILURE DUE TO HEPATITIS B REACTIVATION DURING THE COVID-19 PANDEMIC.
    Gastroenterol Hepatol. 2021 Apr 13. pii: S0210-5705(21)00118.
    PubMed        


    Gastroenterology

  9. CHANG KC, Tsai JH, Su TH
    A Mysterious Case of Jaundice After Development of Skin Vesicles.
    Gastroenterology. 2020;159:1669-1671.
    PubMed        


    Gut

  10. KIM MA, Kim SU, Sinn DH, Jang JW, et al
    Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study.
    Gut. 2020;69:2214-2222.
    PubMed         Abstract available


    Hepatology

  11. ZHOU Y, Dong B, Kim KH, Choi S, et al
    Vitamin D receptor activation in liver macrophages protects against hepatic endoplasmic reticulum stress in mice.
    Hepatology. 2019 Aug 5. doi: 10.1002/hep.30887.
    PubMed         Abstract available

  12. YANG Y, Zhao X, Wang Z, Shu W, et al
    Nuclear Sensor Interferon-Inducible Protein 16 Inhibits the Function of Hepatitis B Virus Covalently Closed Circular DNA by Integrating Innate Immune Activation and Epigenetic Suppression.
    Hepatology. 2020;71:1154-1169.
    PubMed         Abstract available

  13. MATYAS C, Erdelyi K, Trojnar E, Zhao S, et al
    Interplay of liver-heart inflammatory axis and cannabinoid 2 receptor signalling in an experimental model of hepatic cardiomyopathy.
    Hepatology. 2019 Aug 30. doi: 10.1002/hep.30916.
    PubMed         Abstract available

  14. BERTOLETTI A
    ImmTAV, a New Immunotherapy Targeting the Source of HBV Infection.
    Hepatology. 2020;72:1514-1517.
    PubMed        


    J Hepatol

  15. BRIL F, Al Diffalha S, Dean M, Fettig DM, et al
    Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) Vaccine: Causality or casualty?
    J Hepatol. 2021 Apr 13. pii: S0168-8278(21)00237.
    PubMed        

  16. WANG W, Lempp FA, Schlund F, Walter L, et al
    Assembly and infection efficacy of hepatitis B virus surface protein exchanges in eight hepatitis D virus genotype isolates.
    J Hepatol. 2021 Apr 9. pii: S0168-8278(21)00229.
    PubMed         Abstract available

  17. SRIDHAR S, Situ J, Cai JP, Yip CC, et al
    Multimodal investigation of rat hepatitis E virus antigenicity: implications for infection, diagnostics, and vaccine efficacy.
    J Hepatol. 2021 Jan 15. pii: S0168-8278(21)00013.
    PubMed         Abstract available


    J Infect Dis

  18. LIU Z, Huang CJ, Huang YH, Pan MH, et al
    HLA zygosity increases risk of hepatitis B virus-associated hepatocellular carcinoma.
    J Infect Dis. 2021 Apr 14. pii: 6225842. doi: 10.1093.
    PubMed         Abstract available


    PLoS One

  19. KASHIWAKURA JI, Saitoh K, Ihara T, Sasaki Y, et al
    Correction: Expression of signal-transducing adaptor protein-1 attenuates experimental autoimmune hepatitis via down-regulating activation and homeostasis of invariant natural killer T cells.
    PLoS One. 2021;16:e0250536.
    PubMed         Abstract available

  20. AHMED HR, Waly NGFM, Abd El-Baky RM, Yahia R, et al
    Distribution of naturally -occurring NS5B resistance-associated substitutions in Egyptian patients with chronic Hepatitis C.
    PLoS One. 2021;16:e0249770.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: